Xlife Sciences Ltd. XLS
SIX · Switzerland · Commercial Services
CHF 9.800.00 (0.00%)
Market closed· · CHF · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · CHF · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
LOS ANGELES, CA - September 24, 2026 (NEWMEDIAWIRE) - VERAXA Biotech (NASDAQ: VRXA) is shifting its focus to advancing its oncology pipeline and implementing industrial partnerships for its technology platforms and products following the completion o...
Key Insights Significant insider control over Xlife Sciences implies vested interests in company growth 51% of the...
ZURICH - December 23, 2025 (NEWMEDIAWIRE) - Xlife Sciences AG (SIX: XLS) today announced that its Board of Directors has resolved to move from the SIX Sparks segment to the main segment of the SIX Swiss Exchange. This step underscores the compan...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.